Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$637M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$506M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$438M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$277M |
| 5 |
Comcast
CMCSA
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPN
Calpine Corporation
CPN
|
+$298M |
| 2 |
Gilead Sciences
GILD
|
+$235M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$188M |
| 4 |
Apple
AAPL
|
+$180M |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.89% |
| 2 | Energy | 4.68% |
| 3 | Technology | 4.17% |
| 4 | Communication Services | 3.74% |
| 5 | Financials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLK
476
DELISTED
EnLink Midstream Partners, LP
ENLK
| $31.4M | 0.03% |
1,011,364
+1,003,716
| +13,124% | +$30.7M |
|
477
PUT
Humana
HUM
$44.1B
| $31.3M | 0.03% |
246,400
-14,800
| -6% | -$1.75M |
|
478
PUT
Elevance Health
ELV
$84.9B
| $31.2M | 0.03% |
291,600
+218,500
| +299% | +$22.5M |
|
479
Oneok
OKE
$55.4B
| $31.2M | 0.03% |
458,755
+5,532
| +1% | +$350K |
|
480
Camden Property Trust
CPT
$11B
| $31.1M | 0.03% |
437,679
-67,325
| -13% | -$4.68M |
|
481
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$314M
| $31.1M | 0.03% |
517,800
-21,600
| -4% | -$1.38M |
|
|
ESRX
482
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $31M | 0.03% |
449,400
+198,000
| +79% | +$13.9M |
|
|
GPOR
483
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $31M | 0.03% |
499,900
+467,600
| +1,448% | +$31.4M |
|
484
CALL
Visa
V
$692B
| $31M | 0.03% |
589,600
+134,800
| +30% | +$7.05M |
|
|
RAI
485
DELISTED
Reynolds American Inc
RAI
| $30.9M | 0.03% |
1,031,390
-636,768
| -38% | -$18.3M |
|
486
PUT
Bristol-Myers Squibb
BMY
$131B
| $30.8M | 0.03% |
642,400
-2,129,100
| -77% | -$105M |
|
487
Eaton
ETN
$174B
| $30.8M | 0.03% |
400,210
-269,781
| -40% | -$20M |
|
488
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $30.8M | 0.03% |
366,372
+20,395
| +6% | +$1.72M |
|
489
PUT
ProShares Short VIX Short-Term Futures ETF
SVXY
$206M
| $30.6M | 0.03% |
347,300
+108,700
| +46% | +$7.81M |
|
490
Cummins
CMI
$88.7B
| $30.5M | 0.03% |
198,157
-20,109
| -9% | -$3.04M |
|
|
AGN
491
CALL
DELISTED
Allergan Inc
AGN
| $30.5M | 0.03% |
180,500
+90,500
| +101% | +$14.1M |
|
|
CTRX
492
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $30.4M | 0.03% |
690,952
-5,775
| -0.8% | -$244K |
|
|
RAI
493
PUT
DELISTED
Reynolds American Inc
RAI
| $30.4M | 0.03% |
1,012,200
+61,200
| +6% | +$1.76M |
|
|
TIF
494
CALL
DELISTED
Tiffany & Co.
TIF
| $30.2M | 0.03% |
302,300
-109,100
| -27% | -$10.1M |
|
495
CALL
Ashland
ASH
$3.32B
| $30.2M | 0.03% |
571,502
+81,351
| +17% | +$4.06M |
|
496
WisdomTree Japan Hedged Equity Fund
DXJ
$7.35B
| $30.1M | 0.03% |
615,046
-140,581
| -19% | -$6.66M |
|
|
ALXN
497
DELISTED
Alexion Pharmaceuticals
ALXN
| $30.1M | 0.03% |
193,128
-9,737
| -5% | -$1.54M |
|
|
BXUC
498
DELISTED
BARCLAYS LONG C LEVERAGED S&P 500 TR ETN
BXUC
| $30.1M | 0.03% |
105,964
| – | – |
|
499
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $30M | 0.03% |
483,700
-371,700
| -43% | -$22.5M |
|
500
Intuit
INTU
$88.1B
| $29.9M | 0.03% |
373,470
-49,331
| -12% | -$3.81M |
|
Similar funds
Barclays's Q2 2014 Portfolio in Review
As of Q2 2014, Barclays held 8,150 positions worth $94.6B, up 7.1% from $88.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q2 2014 filing shows 480 new, 3,032 increased, 3,756 reduced and 467 closed positions. Its largest new stake was Blackstone Mortgage Trust: 1,000,000 shares worth $29M. The largest sale was Calpine Corporation, an estimated $298M.
By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.8% a quarter earlier, followed by Energy and Technology.
- Barclays's largest Q2 2014 buy was Blackstone Mortgage Trust: 1,000,000 shares worth $29M.
- Barclays added most to Phillips 66 in Q2 2014, an estimated $637M increase.
- Barclays's biggest Q2 2014 reduction was Calpine Corporation, cutting an estimated $298M.
- Barclays fully exited BRE PROPERTIES INC CL A in Q2 2014, selling an estimated $91.7M.
- Barclays's ten largest holdings make up 26% of its $94.6B portfolio in Q2 2014.
- Barclays opened 480 new positions and closed 467 in Q2 2014.
- Barclays's portfolio value rose 7.1% quarter-over-quarter to $94.6B.
Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.